KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Levi Strauss (LEVI) Cash & Equivalents (2016 - 2026)

Levi Strauss' Cash & Equivalents history spans 17 years, with the latest figure at $716.6 million for Q1 2026.

  • For Q1 2026, Cash & Equivalents rose 24.76% year-over-year to $716.6 million; the TTM value through Mar 2026 reached $716.6 million, up 24.76%, while the annual FY2025 figure was $757.9 million, 9.84% up from the prior year.
  • Cash & Equivalents reached $716.6 million in Q1 2026 per LEVI's latest filing, down from $757.9 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $757.9 million in Q4 2025 to a low of $294.5 million in Q3 2023.
  • Average Cash & Equivalents over 5 years is $555.1 million, with a median of $577.1 million recorded in 2024.
  • Peak YoY movement for Cash & Equivalents: tumbled 65.63% in 2022, then surged 95.96% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $429.6 million in 2022, then dropped by 7.17% to $398.8 million in 2023, then surged by 73.02% to $690.0 million in 2024, then rose by 9.84% to $757.9 million in 2025, then decreased by 5.45% to $716.6 million in 2026.
  • Per Business Quant, the three most recent readings for LEVI's Cash & Equivalents are $716.6 million (Q1 2026), $757.9 million (Q4 2025), and $612.8 million (Q3 2025).